Patrick Soon-Shiong's Net Worth

$63.1 Million

Estimate Recalculated Nov 1, 2024 11:09AM EST

Who is Patrick Soon-Shiong

Patrick Soon-Shiong has an estimated net worth of $63.1 Million. This is based on reported shares across multiple companies, which include AMERICAN PHARMACEUTICAL PARTNERS INC /DE/, Abraxis Biosciences, Inc., Sorrento Therapeutics, Inc., ImmunityBio, Inc., tronc, Inc., Benitec Biopharma Inc., Nant Health, LLC, Heliogen, Inc., JAKKS PACIFIC INC, KeyOn Communications Holdings Inc., and NEOMEDIA TECHNOLOGIES INC.

SEC CIK

Patrick Soon-Shiong's CIK is 0001189020

Past Insider Trading and Trends

2016 was Patrick Soon-Shiong's most active year for acquiring shares with 24 total transactions. Patrick Soon-Shiong's most active month to acquire stocks was the month of October. 2010 was Patrick Soon-Shiong's most active year for disposing of shares, totalling 15 transactions. Patrick Soon-Shiong's most active month to dispose stocks was the month of September. 2020 saw Patrick Soon-Shiong paying a total of $44,965,200.00 for 3,710,000 shares, this is the most they've acquired in one year. In 2010 Patrick Soon-Shiong cashed out on 1,004,455 shares for a total of $6,426,716.25, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMERICAN PHARMACEUTICAL PARTNERS INC /DE/

Chairman and CEO

Updated Sep 15, 2008


Form 4	-100.00%	-130.12M	—	—	Sep 15, 2008	—	Disposition	—	Sep 10
Form 4	-0.82%	-1.11M	—	—	Oct 30, 2007	134.63M	Disposition	—	Jan 12 - Oct 26
Form 4	176.04%	84.47M	—	—	Apr 20, 2006	132.46M	Acquisition	—	Apr 18
Form 4	—	40.00K	—	—	Feb 23, 2005	40.00K	Grant	—	Feb 16
Form 4	5.13%	20.00K	—	—	Nov 22, 2004	410.00K	Grant	—	Nov 18
Form 4	—	—	—	—	Sep 29, 2003	757.50K	Grant	—	Sep 19
Form 4	—	—	—	—	Jul 25, 2003	—	—	—	—

Showing 7 results

Abraxis Biosciences, Inc.

Executive Chairman

Updated Oct 19, 2010


Form 4	-100.00%	-33.49M	$11.76	-$5.05M	Oct 19, 2010	—	Disposition	—	Oct 15
Form 4	5.87%	25.00K	—	—	Mar 17, 2010	33.47M	Grant	—	Mar 15
Form 4	-0.54%	-955.00	$32.67	-$31.20K	Mar 03, 2010	33.19M	Tax	—	Mar 10
Form 4	-94.83%	-330.95K	$7.92	-$1.31M	Feb 26, 2010	33.19M	Options	—	Feb 24
Form 4	-100.00%	-8.28K	—	—	Feb 11, 2010	33.03M	Disposition	—	Feb 09
Form 4	-7.11%	-894.00	$41.17	-$36.81K	Jan 26, 2010	33.03M	Tax	—	Jan 15
Form 4	—	—	—	—	Jan 26, 2010	33.04M	Grant	—	Apr 28 - Sep 24
Form 4	8.28%	3.36K	$58.54	-$42.85K	Mar 03, 2009	43.93K	Options	—	Mar 02
Form 4	—	5.64K	—	—	Feb 05, 2009	5.64K	Grant	—	Feb 03
Form 4	3,495.30%	16.36K	$68.24	$541.56K	Nov 07, 2008	16.83K	Grant	—	Nov 05
Form 4	-28.42%	-224.62K	—	—	Apr 22, 2008	565.68K	Disposition	—	Apr 18
Form 4	—	190.93K	—	—	Dec 03, 2007	190.93K	Grant	—	Nov 28
Form 4	—	33.06M	—	—	Nov 16, 2007	33.06M	Acq/Dis	—	Nov 13
Form 3	—	—	—	—	Nov 07, 2007	1.00K	—	—	—

Showing 14 results

Sorrento Therapeutics, Inc.

Investor

Updated Jul 11, 2016

View Quote Details


Form 4	-87.25%	-8.38M	—	—	Jul 11, 2016	1.22M	Sale	—	Jul 28 - Jul 08
Form 4	-0.05%	-3.40K	$5.82	-$19.78K	Jul 01, 2016	9.60M	Sale	—	Jun 29
Form 4	-0.10%	-6.90K	$5.85	-$40.40K	Jun 24, 2016	9.61M	Sale	—	Jun 23
Form 4	-0.28%	-19.84K	$5.87	-$116.48K	Jun 17, 2016	9.61M	Sale	—	Jun 15
Form 4	-6.95%	-53.76K	$6.14	-$329.88K	Jun 15, 2016	9.63M	Sale	—	Jun 13 - Jun 14
Form 4	-11.44%	-100.00K	$6.19	-$619.50K	Mar 08, 2016	9.69M	Sale	—	Mar 04 - Mar 07
Form 4	4.77%	39.76K	$7.93	$315.29K	Dec 10, 2015	9.79M	Grant	—	Dec 09
Form 4	15.83%	114.00K	$7.91	$901.24K	Dec 09, 2015	9.75M	Grant	—	Dec 07 - Dec 08
Form 3	—	—	—	—	Dec 29, 2014	7.91M	—	—	—

Showing 9 results

ImmunityBio, Inc.

See remarks

Updated Feb 26, 2024

View Quote Details


Form 4	—	1.54M	—	—	Feb 26, 2024	1.54M	Grant	—	Feb 22
Form 4	—	—	—	—	Jan 03, 2024	—	Acq/Dis	—	Dec 29
Form 4	209,291.94%	209.29M	$1.29	$269.99M	Sep 13, 2023	532.54M	Purchase	—	Sep 11
Form 4	—	—	—	—	May 16, 2023	—	Purchase	—	May 12
Form 4	—	9.99M	$5.67	$56.63M	Dec 14, 2022	323.24M	Options	—	Dec 12
Form 4	—	—	—	—	Nov 08, 2022	—	Purchase	—	Aug 31
Form 4	—	700.00K	—	—	Mar 25, 2022	700.00K	Grant	—	Mar 23
Form 4	—	26.06K	—	—	Jun 14, 2021	26.06K	Grant	—	Jun 10
Form 4	378.09%	243.21M	—	—	Mar 11, 2021	313.26M	Acquisition	—	Mar 09
Form 4	18.51%	3.71M	$12.12	$44.97M	Jun 29, 2020	69.94M	Purchase	—	Jun 29
Form 4	—	—	$2.02	$39.22M	Mar 21, 2019	66.23M	Options	—	Mar 21
Form 4	—	—	$1.62	$15.00K	Jul 13, 2018	46.78M	Options	—	Jul 11
Form 4	-1.10%	-450.00K	—	—	Jan 04, 2017	46.77M	Grant	—	Dec 30
Form 4	—	5.62M	—	—	Jul 11, 2016	47.23M	Purchase	—	Jul 07
Form 4	—	2.00M	—	—	Oct 16, 2015	2.00M	Purchase	—	Oct 14
Form 4	1.11%	450.00K	$23.00	$10.35M	Aug 25, 2015	41.62M	Purchase	—	Aug 21
Form 4	—	1.50M	—	—	Aug 04, 2015	42.07M	Grant	—	Jul 27
Form 3	—	—	—	—	Jul 27, 2015	40.57M	—	—	—

Showing 18 results

tronc, Inc.

Investor

Updated Mar 21, 2017


Form 4	62.77%	2.95M	$14.87	$43.87M	Mar 21, 2017	8.74M	Purchase	—	Mar 20
Form 4	1.31%	14.14K	$13.91	$196.71K	Feb 21, 2017	5.79M	Purchase	—	Feb 16 - Feb 17
Form 4	0.02%	200.00	$13.49	$2.70K	Dec 12, 2016	5.78M	Purchase	—	Dec 08
Form 4	4.51%	46.61K	$13.41	$625.16K	Dec 08, 2016	5.78M	Purchase	—	Dec 06 - Dec 07
Form 4	3.39%	33.91K	$13.00	$440.92K	Dec 06, 2016	5.73M	Purchase	—	Dec 02 - Dec 05
Form 4	6.96%	65.02K	$12.85	$835.68K	Dec 01, 2016	5.70M	Purchase	—	Nov 29 - Dec 01
Form 4	9.97%	84.67K	$12.92	$1.09M	Nov 28, 2016	5.63M	Purchase	—	Nov 23
Form 4	4.87%	39.46K	$12.71	$501.45K	Nov 23, 2016	5.55M	Purchase	—	Nov 21 - Nov 22
Form 4	8.67%	64.58K	$12.79	$826.08K	Nov 18, 2016	5.51M	Purchase	—	Nov 16 - Nov 18
Form 4	4.79%	34.04K	$12.27	$417.51K	Nov 15, 2016	5.45M	Purchase	—	Nov 11 - Nov 14
Form 4	60.89%	269.08K	$11.29	$3.04M	Nov 10, 2016	5.41M	Purchase	—	Nov 08 - Nov 10
Form 4	7.64%	31.35K	$9.52	$298.54K	Nov 08, 2016	5.14M	Purchase	—	Nov 04 - Nov 07
Form 4	0.84%	3.40K	$12.93	$43.96K	Jun 13, 2016	5.11M	Purchase	—	Jun 09 - Jun 13
Form 4	—	14.94K	—	—	Jun 06, 2016	14.94K	Grant	—	Jun 02
Form 3	—	—	—	—	Jun 06, 2016	5.11M	—	—	—

Showing 15 results

Benitec Biopharma Inc.

Investor

Updated Apr 27, 2020

View Quote Details


Form 3	—	—	—	—	Apr 27, 2020	293.06K	—	—	—

Showing 1 results

Nant Health, LLC

Chief Executive Officer

Updated Aug 30, 2023

View Quote Details


Form 4	—	15.92M	$1.00	$16.00M	Aug 30, 2023	20.38M	Purchase	—	Aug 28
Form 4	—	1.00M	—	—	Sep 13, 2021	1.00M	Grant	—	Sep 09
Form 4	—	62.50M	$1.00	$62.50M	Apr 28, 2021	62.50M	Purchase	—	Apr 27
Form 4	-33.11%	-3.31M	$1.98	-$0.56	Apr 15, 2021	71.80M	Disposition	—	Apr 13
Form 4	-7.44%	-5.00M	—	—	Nov 08, 2019	65.11M	Grant	—	Nov 06
Form 4	—	10.00M	$1.00	$10.00M	Dec 23, 2016	10.00M	Purchase	—	Dec 21
Form 4	0.53%	357.14K	$14.00	$5.00M	Jun 09, 2016	70.11M	Purchase	—	Jun 07
Form 3	—	—	—	—	Jun 01, 2016	69.76M	—	—	—

Showing 8 results

Heliogen, Inc.

Investor

Updated Feb 20, 2024

View Quote Details


Form 4	—	442.30K	$1.52	$672.07K	Feb 20, 2024	1.46M	Purchase	—	Feb 15
Form 4	0.78%	7.36K	$6.49	$47.79K	Sep 06, 2023	1.01M	Purchase	—	Sep 01
Form 4	1.97%	634.25K	$0.23	$146.07K	Jun 26, 2023	35.21M	Purchase	—	Jun 22
Form 4	1.15%	366.66K	$0.23	$85.39K	Jun 21, 2023	34.57M	Purchase	—	Jun 16 - Jun 21
Form 4	5.73%	1.73M	$0.20	$350.64K	Jun 15, 2023	34.21M	Purchase	—	Jun 13 - Jun 15
Form 4	14.15%	3.74M	$0.23	$852.17K	Jun 09, 2023	32.48M	Purchase	—	Jun 07 - Jun 09
Form 4	0.69%	180.01K	$0.25	$44.16K	Jun 05, 2023	28.75M	Purchase	—	Jun 01 - Jun 02
Form 4	0.03%	7.08K	$0.25	$1.77K	Apr 17, 2023	28.57M	Purchase	—	Apr 13
Form 4	2.11%	540.65K	$0.25	$135.04K	Apr 12, 2023	28.56M	Purchase	—	Apr 10 - Apr 12
Form 4	4.16%	1.03M	$0.25	$253.28K	Apr 10, 2023	28.02M	Purchase	—	Apr 05 - Apr 06
Form 4	131.87%	1.33M	$0.23	$306.20K	Mar 27, 2023	26.99M	Purchase	—	Mar 23 - Mar 24
Form 4	—	25.66M	—	—	Jul 05, 2022	25.66M	Grant	—	Dec 30
Form 3	—	—	—	—	Jul 05, 2022	—	—	—	—

Showing 13 results

JAKKS PACIFIC INC

Investor

Updated Jul 25, 2016

View Quote Details


Form 4	-2.71%	-133.62K	$8.73	-$1.18M	Jul 25, 2016	6.54M	Sale	—	Jul 07 - Jul 22
Form 4	-1.24%	-30.00K	$8.80	-$264.12K	Jul 21, 2016	4.13M	Sale	—	Jul 19 - Jul 20
Form 4	-3.96%	-100.00K	$8.62	-$862.30K	Jul 20, 2016	4.16M	Sale	—	Jul 18
Form 4	-0.53%	-13.40K	$8.53	-$114.31K	Jul 18, 2016	4.26M	Sale	—	Jul 14
Form 4	-1.10%	-28.27K	$8.62	-$243.75K	Jul 14, 2016	4.28M	Sale	—	Jul 12
Form 4	-0.84%	-21.81K	$8.43	-$183.86K	Jul 12, 2016	4.31M	Sale	—	Jul 08 - Jul 11
Form 4	-3.72%	-100.00K	$8.20	-$819.60K	Jul 08, 2016	4.33M	Sale	—	Jul 06
Form 4	-0.26%	-7.00K	$8.07	-$56.52K	Jul 06, 2016	4.43M	Sale	—	Jul 01
Form 4	-1.04%	-28.19K	$7.85	-$221.21K	Jul 01, 2016	4.43M	Sale	—	Jun 29 - Jun 30
Form 4	-1.35%	-37.19K	$7.84	-$291.47K	Jun 24, 2016	4.46M	Sale	—	Jun 22 - Jun 24
Form 4	-0.34%	-9.31K	$7.82	-$72.78K	Jun 22, 2016	4.50M	Sale	—	Jun 20
Form 4	-0.69%	-19.16K	$7.94	-$152.13K	Jun 17, 2016	4.51M	Sale	—	Jun 15
Form 4	-1.17%	-33.11K	$7.81	-$258.47K	Jun 15, 2016	4.53M	Sale	—	Jun 13 - Jun 14
Form 4	-3.04%	-88.61K	$7.86	-$696.38K	Jun 13, 2016	4.56M	Sale	—	Jun 09 - Jun 10
Form 4	-1.70%	-50.34K	$7.74	-$389.58K	Jun 09, 2016	4.65M	Sale	—	Jun 07 - Jun 08
Form 4	-25.25%	-1.00M	$7.45	-$7.45M	Mar 04, 2016	4.70M	Sale	—	Mar 03
Form 4	-3.88%	-159.90K	$8.00	-$1.28M	Nov 24, 2015	5.70M	Sale	—	Nov 20 - Nov 23
Form 4	-1.60%	-66.89K	$9.46	-$632.87K	Sep 01, 2015	5.86M	Sale	—	Aug 28 - Aug 31
Form 4	46.85%	1.34M	$7.41	$9.90M	Jul 22, 2013	5.93M	Purchase	—	Jul 18
Form 4/A	40.52%	2.22M	$11.47	$27.39M	Jul 15, 2013	9.21M	Purchase	—	Oct 01 - Apr 09
Form 3/A	—	—	—	—	Jul 15, 2013	866.77K	—	—	—
Form 3	—	—	—	—	Apr 09, 2013	2.23M	—	—	—
Form 4	38.45%	858.58K	$10.42	$8.95M	Apr 09, 2013	3.09M	Purchase	—	Apr 05 - Apr 09

Showing 23 results

KeyOn Communications Holdings Inc.

Investor

Updated Apr 11, 2011


Form 3/A	—	—	—	—	Apr 11, 2011	—	—	—	—
Form 3	—	—	—	—	Apr 08, 2011	—	—	—	—

Showing 2 results

NEOMEDIA TECHNOLOGIES INC

Investor

Updated Mar 20, 2012


Form 4	159.48%	69.75M	$0.04	$3.08M	Mar 20, 2012	113.49M	Purchase	—	Mar 16
Form 3	—	—	—	—	Mar 20, 2012	113.49M	—	—	—

Showing 2 results

Panbela Therapeutics, Inc.

Investor

Updated Oct 29, 2024

View Quote Details


Form 3	—	—	—	—	Oct 29, 2024	—	—	—	—

Showing 1 results